IBM, Verizon, Corning And A Health Care Stock On CNBC’s ‘Final Trades’
On CNBC’s “ Halftime Report Final Trades,” Jim Lebenthal, partner and chief market strategist at Cerity Partners, said Vertex Pharmaceuticals Inc (NASDAQ: VRTX ) is a great name to own in the health care sector. As per the recent news, Vertex Pharmaceuticals, on June 11, reported new clinical data showing that CASGEVY